The European seed and plant breeding sector is undergoing rapid technological and regulatory transformation, driven by advances in biotechnology, climate pressures, and shifting policy expectations. In this context, the European Commission commissioned this study to assess how the current intellectual property (IP) framework—particularly regarding patents on new genomic techniques (NGTs), traits, and processes—affects innovation, breeders’ access to genetic material, and the availability of seeds to farmers.
Purpose and Approach
The study evaluates the economic and legal implications of the EU’s IP architecture for plant breeding, focusing on how patents intersect with Plant Variety Rights (PVRs) and the evolving use of NGTs. Its methodology combines legal and economic analysis, extensive desk research, 29 stakeholder interviews, expert panels, and empirical evidence from patent and company databases.
Sector Overview
Europe’s plant breeding sector is technologically advanced and diverse, dominated by small and medium-sized breeders alongside a handful of global leaders. Research intensity is high, with R&D averaging 16% of turnover. NGT research is expanding globally, though EU activity remains a modest share. The EU is the world’s second-largest seed market, with strong technical expertise but increasing consolidation as firms seek scale.
Patent Landscape and Regulation
Patent activity in plant biotechnology is significant but highly scrutinised, with falling granting rates at the European Patent Office. PVRs, patents, trade secrets, and licensing agreements collectively shape innovation incentives and access to genetic resources. However, the coexistence of multiple legal regimes creates complexity. SMEs in particular struggle with navigating NGT-related patents and conducting costly freedom-to-operate analyses.
Private and public mechanisms support access to patented material—including voluntary licensing platforms, transparency databases, breeder’s and farmer’s exemptions, and SME support schemes—but gaps remain, especially around patent clarity and foundational technology licensing.
Key Challenges
NGT adoption magnifies concerns about complex patent landscapes, especially for SMEs with limited legal capacity. Risks include barriers to accessing genetic material, rising licensing costs, and potential market concentration favouring large firms. Farmers may face higher seed prices and fewer non-patented options if access constraints persist.
Opportunities for Improvement
Stakeholders broadly support maintaining patents while strengthening transparency and access. Promising avenues include:
- Integrating patent and plant variety databases to ease access to IP information.
- Expanding SME support through training, legal advisory services, and funding for IP management.
- Ensuring publicly funded innovations are licensed on fair terms to encourage diffusion.
- Strengthening voluntary licensing platforms and standardising licensing practices, potentially through FRAND-style models.
- Monitoring market developments to preserve diverse, accessible plant reproductive material.
Conclusion
A balanced IP system—combining robust patent protection and effective PVRs—is essential to fostering innovation, investment, and competitiveness in Europe’s plant breeding and biotechnology sectors. Enhancing transparency, supporting SMEs, and ensuring access to genetic resources will help maintain this balance as NGTs become more central to breeding strategies, safeguarding both innovation and diversity in the EU bioeconomy.
European Union, 'Supporting innovation in the EU bioeconomy through intellectual property protection', Publications Office of the European Union, 2025, doi: 10.2873/1409197
Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs
